Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 1.09
CHDX's Cash to Debt is ranked higher than
65% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.66 vs. CHDX: 1.09 )
CHDX' s 10-Year Cash to Debt Range
Min: 0.77   Max: No Debt
Current: 1.09

Equity to Asset 0.68
CHDX's Equity to Asset is ranked higher than
83% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. CHDX: 0.68 )
CHDX' s 10-Year Equity to Asset Range
Min: 0.32   Max: 0.72
Current: 0.68

0.32
0.72
Interest Coverage 1.19
CHDX's Interest Coverage is ranked lower than
63% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 24.59 vs. CHDX: 1.19 )
CHDX' s 10-Year Interest Coverage Range
Min: 0.93   Max: 9999.99
Current: 1.19

0.93
9999.99
F-Score: 6
Z-Score: 4.15
M-Score: -2.59
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 1.49
CHDX's Operating margin (%) is ranked lower than
56% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.29 vs. CHDX: 1.49 )
CHDX' s 10-Year Operating margin (%) Range
Min: -714.57   Max: 8.42
Current: 1.49

-714.57
8.42
Net-margin (%) -3.42
CHDX's Net-margin (%) is ranked lower than
67% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.88 vs. CHDX: -3.42 )
CHDX' s 10-Year Net-margin (%) Range
Min: -19.33   Max: 4.79
Current: -3.42

-19.33
4.79
ROE (%) -3.69
CHDX's ROE (%) is ranked lower than
62% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.25 vs. CHDX: -3.69 )
CHDX' s 10-Year ROE (%) Range
Min: -32.39   Max: 9.8
Current: -3.69

-32.39
9.8
ROA (%) -2.51
CHDX's ROA (%) is ranked lower than
64% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.83 vs. CHDX: -2.51 )
CHDX' s 10-Year ROA (%) Range
Min: -17.29   Max: 4.8
Current: -2.51

-17.29
4.8
ROC (Joel Greenblatt) (%) 2.36
CHDX's ROC (Joel Greenblatt) (%) is ranked lower than
64% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.42 vs. CHDX: 2.36 )
CHDX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5307.74   Max: 35.19
Current: 2.36

-5307.74
35.19
Revenue Growth (%) 0.20
CHDX's Revenue Growth (%) is ranked lower than
57% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.80 vs. CHDX: 0.20 )
CHDX' s 10-Year Revenue Growth (%) Range
Min: -24   Max: 100.4
Current: 0.2

-24
100.4
EBITDA Growth (%) -13.40
CHDX's EBITDA Growth (%) is ranked lower than
59% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.10 vs. CHDX: -13.40 )
CHDX' s 10-Year EBITDA Growth (%) Range
Min: -22.4   Max: 71.8
Current: -13.4

-22.4
71.8
» CHDX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

CHDX Guru Trades in

Q2 2012

CHDX Guru Trades in Q2 2012

Jim Simons Sold Out
» More
Q1 2013

CHDX Guru Trades in Q1 2013

Jim Simons 14,311 sh (New)
» More
Q2 2013

CHDX Guru Trades in Q2 2013

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with CHDX



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.60
CHDX's P/B is ranked higher than
50% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.13 vs. CHDX: 2.60 )
CHDX' s 10-Year P/B Range
Min: 0.55   Max: 8.09
Current: 2.6

0.55
8.09
P/S 2.20
CHDX's P/S is ranked lower than
65% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.50 vs. CHDX: 2.20 )
CHDX' s 10-Year P/S Range
Min: 0.11   Max: 2.87
Current: 2.2

0.11
2.87
EV-to-EBIT 166.70
CHDX's EV-to-EBIT is ranked lower than
75% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.09 vs. CHDX: 166.70 )
CHDX' s 10-Year EV-to-EBIT Range
Min: 1.4   Max: 506.7
Current: 166.7

1.4
506.7
Shiller P/E 105.80
CHDX's Shiller P/E is ranked lower than
61% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 31.71 vs. CHDX: 105.80 )
CHDX' s 10-Year Shiller P/E Range
Min: 26.03   Max: 757.5
Current: 105.8

26.03
757.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.57
CHDX's Price/Tangible Book is ranked higher than
61% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.08 vs. CHDX: 2.57 )
CHDX' s 10-Year Price/Tangible Book Range
Min: 0.18   Max: 4.7
Current: 2.57

0.18
4.7
Price/DCF (Projected) 4.74
CHDX's Price/DCF (Projected) is ranked lower than
56% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.25 vs. CHDX: 4.74 )
CHDX' s 10-Year Price/DCF (Projected) Range
Min: 1.37   Max: 8.9
Current: 4.74

1.37
8.9
Price/Median PS Value 1.83
CHDX's Price/Median PS Value is ranked lower than
72% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.22 vs. CHDX: 1.83 )
CHDX' s 10-Year Price/Median PS Value Range
Min: 0.08   Max: 2.07
Current: 1.83

0.08
2.07
Earnings Yield (Greenblatt) 0.60
CHDX's Earnings Yield (Greenblatt) is ranked lower than
71% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.90 vs. CHDX: 0.60 )
CHDX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 73.2
Current: 0.6

0.2
73.2
Forward Rate of Return (Yacktman) -0.89
CHDX's Forward Rate of Return (Yacktman) is ranked lower than
54% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.26 vs. CHDX: -0.89 )
CHDX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -13.8   Max: 29.3
Current: -0.89

-13.8
29.3

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Chindex International, Inc., was founded in 1981 in Delaware. The Company operates in several healthcare markets in China, including Hong Kong. It generates its revenue from the provision of healthcare services and the sale of medical equipment, instrumentation and products. The Company operates in two business segments: the Medical Product Division and the Healthcare Services Division. It operates hospitals and clinics in Beijing, Shanghai, Tianjin and Guangzhou. These hospitals and clinics generally transact business in Chinese Renminbi. The Company historically also engaged in the distribution of western medical equipment to Chinese hospital purchasers through its former Medical Products division ("MPD"). Its Healthcare Services Business includes: United Family Beijing Market - Beijing United Family Hospital (BJU) and Clinics, United Family Shanghai Market—Shanghai United Family Hospital (SHU) and Clinics, United Family Tianjin Market - Tianjin United Family Hospital (TJU), United Family Guangzhou Market - Guangzhou United Family Clinic (GZC), United Family - The Investment Environment and New Market Development. There are no foreign investor-owned and operated hospital networks in China that compete with the United Family healthcare network in serving the expatriate, diplomatic and affluent local Chinese markets through a healthcare service delivery system.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide